Skip to main content
Top
Published in: Heart and Vessels 11/2019

01-11-2019 | Adenovirus | Original Article

YKL-40 promotes the progress of atherosclerosis independent of lipid metabolism in apolipoprotein E−/− mice fed a high-fat diet

Authors: Lei Chen, Jianlei Zheng, Qi Xue, Yan Zhao

Published in: Heart and Vessels | Issue 11/2019

Login to get access

Abstract

YKL-40 is recently regarded as a pro-inflammatory cytokine involved in the pathological process of atherosclerosis and lipid metabolism. However, whether YKL-40 can directly influence the development of atherosclerosis and levels of lipid parameters is unknown. The aim of this study is to explore the effects of YKL-40 on atherosclerotic features, the levels of serum lipids, and biomarkers in apolipoprotein (E)-deficient (ApoE−/−) mice fed a high-fat diet. ApoE−/− mice were injected with a recombinant adenovirus expressing mouse YKL-40 or control adenovirus through the caudal vein. The levels of serum YKL-40, interleukin-6 (IL-6), tumour necrosis factor-alpha (TNF-alpha), matrix metalloproteinase-9 (MMP-9), and soluble vascular cell-adhesion molecule 1 (sVCAM-1) were measured by ELISA. Lipid metabolism parameters were measured using immunoturbidimetric assay. The size of plaque area in aorta was evaluated by Oil Red O and hematoxylin/eosin (HE) staining. The content of collagen fibers was stained with Masson, and the content of macrophages and smooth muscle cells (SMCs) in atherosclerotic lesions was investigated by immunohistochemistry. The serum levels of total cholesterol and triglycerides were similar between these two groups. Compared with the control, the levels of serum YKL-40, IL-6, TNF-alpha, MMP-9, plaque size, and macrophages in plaques were significantly increased in mice with adenovirus overexpressing YKL-40. However, the content of collagen fibers and SMCs was remarkably decreased in mice with adenovirus overexpressing YKL-40 than that in control. YKL-40 prompts the progress of atherosclerosis maybe involved with its role of pro-inflammation, but does not affect lipid metabolism in ApoE−/− mice fed a high-fat diet.
Literature
1.
go back to reference Ellulu MS, Patimah I, Khaza'ai H, Rahmat A, Abed Y, Ali F (2016) Atherosclerotic cardiovascular disease: a review of initiators and protective factors. Inflammopharmacology 24(1):1–10CrossRef Ellulu MS, Patimah I, Khaza'ai H, Rahmat A, Abed Y, Ali F (2016) Atherosclerotic cardiovascular disease: a review of initiators and protective factors. Inflammopharmacology 24(1):1–10CrossRef
2.
go back to reference Greenland P, Blaha MJ, Budoff MJ, Erbel R, Watson KE (2018) Coronary calcium score and cardiovascular risk. J Am Coll Cardiol 72(4):434–447CrossRef Greenland P, Blaha MJ, Budoff MJ, Erbel R, Watson KE (2018) Coronary calcium score and cardiovascular risk. J Am Coll Cardiol 72(4):434–447CrossRef
3.
go back to reference Usman A, Ribatti D, Sadat U, Gillard JH (2015) From Lipid retention to immune-mediate inflammation and associated angiogenesis in the pathogenesis of atherosclerosis. J Atheroscler Thromb 22(8):739–749CrossRef Usman A, Ribatti D, Sadat U, Gillard JH (2015) From Lipid retention to immune-mediate inflammation and associated angiogenesis in the pathogenesis of atherosclerosis. J Atheroscler Thromb 22(8):739–749CrossRef
4.
go back to reference Johnson JL (2017) Metalloproteinases in atherosclerosis. Eur J Pharmacol 816:93–106CrossRef Johnson JL (2017) Metalloproteinases in atherosclerosis. Eur J Pharmacol 816:93–106CrossRef
5.
go back to reference Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R (2013) Update on acute coronary syndromes: the pathologists' view. Eur Heart J 34(10):719–728CrossRef Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R (2013) Update on acute coronary syndromes: the pathologists' view. Eur Heart J 34(10):719–728CrossRef
6.
go back to reference Rathcke CN, Vestergaard H (2009) YKL-40–an emerging biomarker in cardiovascular disease and diabetes. Cardiovasc Diabetol 8:61CrossRef Rathcke CN, Vestergaard H (2009) YKL-40–an emerging biomarker in cardiovascular disease and diabetes. Cardiovasc Diabetol 8:61CrossRef
7.
go back to reference Ma CY, Xu ZY, Wang SP, Peng HY, Liu F, Liu JH, Ren FX (2018) Change of inflammatory factors in patients with acute coronary syndrome. Chin Med J (Engl) 131(12):1444–1449CrossRef Ma CY, Xu ZY, Wang SP, Peng HY, Liu F, Liu JH, Ren FX (2018) Change of inflammatory factors in patients with acute coronary syndrome. Chin Med J (Engl) 131(12):1444–1449CrossRef
8.
go back to reference Nøjgaard C, Høst NB, Christensen IJ, Poulsen SH, Egstrup K, Price PA, Johansen JS (2008) Serum levels of YKL-40 increases in patients with acute myocardial infarction. Coron Artery Dis 19(4):257–263CrossRef Nøjgaard C, Høst NB, Christensen IJ, Poulsen SH, Egstrup K, Price PA, Johansen JS (2008) Serum levels of YKL-40 increases in patients with acute myocardial infarction. Coron Artery Dis 19(4):257–263CrossRef
9.
go back to reference Rathcke CN, Raymond I, Kistorp C, Hildebrandt P, Faber J, Vestergaard H (2010) Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population. Int J Cardiol 143(1):35–42CrossRef Rathcke CN, Raymond I, Kistorp C, Hildebrandt P, Faber J, Vestergaard H (2010) Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population. Int J Cardiol 143(1):35–42CrossRef
10.
go back to reference Zheng JL, Lu L, Hu J, Zhang RY, Zhang Q, Chen QJ, Shen WF (2010) Increased serum YKL-40 and C-reactive protein levels are associated with angiographic lesion progression in patients with coronary artery disease. Atherosclerosis 210(2):590–595CrossRef Zheng JL, Lu L, Hu J, Zhang RY, Zhang Q, Chen QJ, Shen WF (2010) Increased serum YKL-40 and C-reactive protein levels are associated with angiographic lesion progression in patients with coronary artery disease. Atherosclerosis 210(2):590–595CrossRef
11.
go back to reference Kjaergaard AD, Johansen JS, Bojesen SE, Nordestgaard BG (2015) Elevated plasma YKL-40, lipids and lipoproteins, and ischemic vascular disease in the general population. Stroke 46(2):329–335CrossRef Kjaergaard AD, Johansen JS, Bojesen SE, Nordestgaard BG (2015) Elevated plasma YKL-40, lipids and lipoproteins, and ischemic vascular disease in the general population. Stroke 46(2):329–335CrossRef
12.
go back to reference Thomsen SB, Gjesing AP, Rathcke CN, Ekstrom CT, Eiberg H, Hansen T, Pedersen O, Vestergaard H (2015) Associations of the inflammatory marker YKL-40 with measures of obesity and dyslipidaemia in individuals at high risk of type 2 diabetes. PLoS ONE 10(7):e0133672CrossRef Thomsen SB, Gjesing AP, Rathcke CN, Ekstrom CT, Eiberg H, Hansen T, Pedersen O, Vestergaard H (2015) Associations of the inflammatory marker YKL-40 with measures of obesity and dyslipidaemia in individuals at high risk of type 2 diabetes. PLoS ONE 10(7):e0133672CrossRef
13.
go back to reference Thomsen SB, Rathcke CN, Skaaby T, Linneberg A, Vestergaard H (2012) The association between genetic variations of CHI3L1, levels of the encoded glycoprotein YKL-40 and the lipid profile in a Danish population. PLoS ONE 7(10):e47094CrossRef Thomsen SB, Rathcke CN, Skaaby T, Linneberg A, Vestergaard H (2012) The association between genetic variations of CHI3L1, levels of the encoded glycoprotein YKL-40 and the lipid profile in a Danish population. PLoS ONE 7(10):e47094CrossRef
14.
go back to reference Kologlu T, Ucar SK, Levent E, Akcay YD, Coker M, Sozmen EY (2014) Chitotriosidase as a possible marker of clinically evidenced atherosclerosis in dyslipidemic children. J Pediatr Endocrinol Metab 27(7–8):701–708PubMed Kologlu T, Ucar SK, Levent E, Akcay YD, Coker M, Sozmen EY (2014) Chitotriosidase as a possible marker of clinically evidenced atherosclerosis in dyslipidemic children. J Pediatr Endocrinol Metab 27(7–8):701–708PubMed
15.
go back to reference Tang H, Sun Y, Shi Z, Huang H, Fang Z, Chen J, Xiu Q, Li B (2013) YKL-40 induces IL-8 expression from bronchial epithelium via MAPK (JNK and ERK) and NF-κB pathways, causing bronchial smooth muscle proliferation and migration. J Immunol 190(1):438–446CrossRef Tang H, Sun Y, Shi Z, Huang H, Fang Z, Chen J, Xiu Q, Li B (2013) YKL-40 induces IL-8 expression from bronchial epithelium via MAPK (JNK and ERK) and NF-κB pathways, causing bronchial smooth muscle proliferation and migration. J Immunol 190(1):438–446CrossRef
16.
go back to reference Kucur M, Isman FK, Balci C, Onal B, Hacibekiroglu M, Ozkan F, Ozkan A (2008) Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia. Urol Oncol 26(1):47–52CrossRef Kucur M, Isman FK, Balci C, Onal B, Hacibekiroglu M, Ozkan F, Ozkan A (2008) Serum YKL-40 levels and chitotriosidase activity as potential biomarkers in primary prostate cancer and benign prostatic hyperplasia. Urol Oncol 26(1):47–52CrossRef
17.
go back to reference Li LL, Fan JT, Li DH, Liu Y (2016) Effects of a small interfering RNA targeting YKL-40 gene on the proliferation and invasion of endometrial cancer HEC-1A cells. Int J Gynecol Cancer 26(7):1190–1195CrossRef Li LL, Fan JT, Li DH, Liu Y (2016) Effects of a small interfering RNA targeting YKL-40 gene on the proliferation and invasion of endometrial cancer HEC-1A cells. Int J Gynecol Cancer 26(7):1190–1195CrossRef
18.
go back to reference Faibish M, Francescone R, Bentley B, Yan W, Shao R (2011) A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers. Mol Cancer Ther 10(5):742–751CrossRef Faibish M, Francescone R, Bentley B, Yan W, Shao R (2011) A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers. Mol Cancer Ther 10(5):742–751CrossRef
19.
go back to reference Tapia-Vieyra JV, Delgado-Coello B, Mas-Oliva J (2017) Atherosclerosis and cancer; a resemblance with far-reaching implications. Arch Med Res 48(1):12–26CrossRef Tapia-Vieyra JV, Delgado-Coello B, Mas-Oliva J (2017) Atherosclerosis and cancer; a resemblance with far-reaching implications. Arch Med Res 48(1):12–26CrossRef
20.
go back to reference Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R (2010) Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 30(7):1282–1292CrossRef Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R (2010) Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol 30(7):1282–1292CrossRef
21.
go back to reference de la Sierra A, Pintó X, Guijarro C, Miranda JL, Callejo D, Cuervo J, Subirà R, Rubio M (2015) Prevalence, treatment, and control of hypercholesterolemia in high cardiovascular risk patients: evidences from a systematic literature review in Spain. Adv Ther 32(10):944–961CrossRef de la Sierra A, Pintó X, Guijarro C, Miranda JL, Callejo D, Cuervo J, Subirà R, Rubio M (2015) Prevalence, treatment, and control of hypercholesterolemia in high cardiovascular risk patients: evidences from a systematic literature review in Spain. Adv Ther 32(10):944–961CrossRef
22.
go back to reference Buckley ML (1852) Ramji DP (2015) The influence of dysfunctional signaling and lipid homeostasis in mediating the inflammatory responses during atherosclerosis. Biochim Biophys Acta 7:1498–1510 Buckley ML (1852) Ramji DP (2015) The influence of dysfunctional signaling and lipid homeostasis in mediating the inflammatory responses during atherosclerosis. Biochim Biophys Acta 7:1498–1510
23.
go back to reference Masajtis-Zagajewska A, Majer J, Nowicki M (2010) Effect of moxonidine and amlodipine on serum YKL-40, plasma lipids and insulin sensitivity in insulin-resistant hypertensive patients-a randomized, crossover trial. Hypertens Res 33(4):348–353CrossRef Masajtis-Zagajewska A, Majer J, Nowicki M (2010) Effect of moxonidine and amlodipine on serum YKL-40, plasma lipids and insulin sensitivity in insulin-resistant hypertensive patients-a randomized, crossover trial. Hypertens Res 33(4):348–353CrossRef
24.
go back to reference Kawada M, Seno H, Kanda K, Nakanishi Y, Akitake R, Komekado H, Kawada K, Sakai Y, Mizoguchi E, Chiba T (2012) Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer. Oncogene 31(26):3111–3123CrossRef Kawada M, Seno H, Kanda K, Nakanishi Y, Akitake R, Komekado H, Kawada K, Sakai Y, Mizoguchi E, Chiba T (2012) Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer. Oncogene 31(26):3111–3123CrossRef
25.
go back to reference Jingjing Z, Nan Z, Wei W, Qinghe G, Weijuan W, Peng W, Xiangpeng W (2017) MicroRNA-24 modulates Staphylococcus aureus-induced macrophage polarization by suppressing CHI3L1. Inflammation 40(3):995–1005CrossRef Jingjing Z, Nan Z, Wei W, Qinghe G, Weijuan W, Peng W, Xiangpeng W (2017) MicroRNA-24 modulates Staphylococcus aureus-induced macrophage polarization by suppressing CHI3L1. Inflammation 40(3):995–1005CrossRef
26.
go back to reference Gustafson B (2010) Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb 17(4):332–341CrossRef Gustafson B (2010) Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb 17(4):332–341CrossRef
27.
go back to reference Kleemann R, Zadelaar S, Kooistra T (2008) Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res 79(3):360–376CrossRef Kleemann R, Zadelaar S, Kooistra T (2008) Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res 79(3):360–376CrossRef
28.
go back to reference Brown RA, Shantsila E, Varma C, Lip GY (2017) Current understanding of atherogenesis. Am J Med 130(3):268–282CrossRef Brown RA, Shantsila E, Varma C, Lip GY (2017) Current understanding of atherogenesis. Am J Med 130(3):268–282CrossRef
29.
go back to reference Kang J, Kim HL, Seo JB, Lee JY, Moon MK, Chung WY (2018) Endothelial function estimated by digital reactive hyperemia in patients with atherosclerotic risk factors or coronary artery disease. Heart Vessels 33(7):706–712CrossRef Kang J, Kim HL, Seo JB, Lee JY, Moon MK, Chung WY (2018) Endothelial function estimated by digital reactive hyperemia in patients with atherosclerotic risk factors or coronary artery disease. Heart Vessels 33(7):706–712CrossRef
30.
go back to reference Dimas GG, Didangelos TP, Grekas DM (2017) Matrix gelatinases in atherosclerosis and diabetic nephropathy: progress and challenges. Curr Vasc Pharmacol 15(6):557–565CrossRef Dimas GG, Didangelos TP, Grekas DM (2017) Matrix gelatinases in atherosclerosis and diabetic nephropathy: progress and challenges. Curr Vasc Pharmacol 15(6):557–565CrossRef
31.
go back to reference Fukuda D, Shimada K, Tanaka A, Kusuyama T, Yamashita H, Ehara S, Nakamura Y, Kawarabayashi T, Iida H, Yoshiyama M, Yoshikawa J (2006) Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris. Am J Cardiol 97(2):175–180CrossRef Fukuda D, Shimada K, Tanaka A, Kusuyama T, Yamashita H, Ehara S, Nakamura Y, Kawarabayashi T, Iida H, Yoshiyama M, Yoshikawa J (2006) Comparison of levels of serum matrix metalloproteinase-9 in patients with acute myocardial infarction versus unstable angina pectoris versus stable angina pectoris. Am J Cardiol 97(2):175–180CrossRef
32.
go back to reference Wu Y, Tao Z, Song C, Jia Q, Bai J, Zhi K, Qu L (2013) Overexpression of YKL-40 predicts plaque instability in carotid atherosclerosis with CagA-positive Helicobacter pylori infection. PLoS ONE 8(4):e59996CrossRef Wu Y, Tao Z, Song C, Jia Q, Bai J, Zhi K, Qu L (2013) Overexpression of YKL-40 predicts plaque instability in carotid atherosclerosis with CagA-positive Helicobacter pylori infection. PLoS ONE 8(4):e59996CrossRef
33.
go back to reference Michelsen AE, Rathcke CN, Skjelland M, Holm S, Ranheim T, Krohg-Sorensen K, Klingvall MF, Brosstad F, Oie E, Vestergaard H, Aukrust P, Halvorsen B (2010) Increased YKL-40 expression in patients with carotid atherosclerosis. Atherosclerosis 211(2):589–595CrossRef Michelsen AE, Rathcke CN, Skjelland M, Holm S, Ranheim T, Krohg-Sorensen K, Klingvall MF, Brosstad F, Oie E, Vestergaard H, Aukrust P, Halvorsen B (2010) Increased YKL-40 expression in patients with carotid atherosclerosis. Atherosclerosis 211(2):589–595CrossRef
34.
go back to reference Ren HY, Khera A, de Lemos JA, Ayers CR, Rohatgi A (2017) Soluble endothelial cell-selective adhesion molecule and incident cardiovascular events in a multiethnic population. Am Heart J 191:55–61CrossRef Ren HY, Khera A, de Lemos JA, Ayers CR, Rohatgi A (2017) Soluble endothelial cell-selective adhesion molecule and incident cardiovascular events in a multiethnic population. Am Heart J 191:55–61CrossRef
35.
go back to reference Raggi P, Genest J, Giles JT, Rayner KJ, Dwivedi G, Beanlands RS, Gupta M (2018) Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. Atherosclerosis 276:98–108CrossRef Raggi P, Genest J, Giles JT, Rayner KJ, Dwivedi G, Beanlands RS, Gupta M (2018) Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. Atherosclerosis 276:98–108CrossRef
36.
go back to reference Christodoulou E, Kadoglou NPE, Stasinopoulou M, Konstandi OA, Kenoutis C, Kakazanis ZI, Rizakou A, Kostomitsopoulos N, Valsami G (2018) Crocus sativus L. aqueous extract reduces atherogenesis, increases atherosclerotic plaque stability and improves glucose control in diabetic atherosclerotic animals. Atherosclerosis 268:207–214CrossRef Christodoulou E, Kadoglou NPE, Stasinopoulou M, Konstandi OA, Kenoutis C, Kakazanis ZI, Rizakou A, Kostomitsopoulos N, Valsami G (2018) Crocus sativus L. aqueous extract reduces atherogenesis, increases atherosclerotic plaque stability and improves glucose control in diabetic atherosclerotic animals. Atherosclerosis 268:207–214CrossRef
37.
go back to reference Chen Q, Jin M, Yang F, Zhu J, Xiao Q, Zhang L (2013) Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediat Inflamm 2013:928315 Chen Q, Jin M, Yang F, Zhu J, Xiao Q, Zhang L (2013) Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediat Inflamm 2013:928315
38.
go back to reference Ma S, Motevalli SM, Chen J, Xu MQ, Wang Y, Feng J, Qiu Y, Han D, Fan M, Ding M, Fan L, Guo W, Liang XJ, Cao F (2018) Precise theranostic nanomedicines for inhibiting vulnerable atherosclerotic plaque progression through regulation of vascular smooth muscle cell phenotype switching. Theranostics 8(13):3693–3706CrossRef Ma S, Motevalli SM, Chen J, Xu MQ, Wang Y, Feng J, Qiu Y, Han D, Fan M, Ding M, Fan L, Guo W, Liang XJ, Cao F (2018) Precise theranostic nanomedicines for inhibiting vulnerable atherosclerotic plaque progression through regulation of vascular smooth muscle cell phenotype switching. Theranostics 8(13):3693–3706CrossRef
39.
go back to reference Pidkovka NA, Cherepanova OA, Yoshida T, Alexander MR, Deaton RA, Thomas JA, Leitinger N, Owens GK (2007) Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro. Circ Res 101(8):792–801CrossRef Pidkovka NA, Cherepanova OA, Yoshida T, Alexander MR, Deaton RA, Thomas JA, Leitinger N, Owens GK (2007) Oxidized phospholipids induce phenotypic switching of vascular smooth muscle cells in vivo and in vitro. Circ Res 101(8):792–801CrossRef
40.
go back to reference Tai LM, Thomas R, Marottoli FM, Koster KP, Kanekiyo T, Morris AW, Bu G (2016) The role of APOE in cerebrovascular dysfunction. Acta Neuropathol 131(5):709–723CrossRef Tai LM, Thomas R, Marottoli FM, Koster KP, Kanekiyo T, Morris AW, Bu G (2016) The role of APOE in cerebrovascular dysfunction. Acta Neuropathol 131(5):709–723CrossRef
41.
go back to reference Zhao J, Davis MD, Martens YA, Shinohara M, Graff-Radford NR, Younkin SG, Wszolek ZK, Kanekiyo T, Bu G (2017) APOE ε4/ε4 diminishes neurotrophic function of human iPSC-derived astrocytes. Hum Mol Genet 26(14):2690–2700CrossRef Zhao J, Davis MD, Martens YA, Shinohara M, Graff-Radford NR, Younkin SG, Wszolek ZK, Kanekiyo T, Bu G (2017) APOE ε4/ε4 diminishes neurotrophic function of human iPSC-derived astrocytes. Hum Mol Genet 26(14):2690–2700CrossRef
Metadata
Title
YKL-40 promotes the progress of atherosclerosis independent of lipid metabolism in apolipoprotein E−/− mice fed a high-fat diet
Authors
Lei Chen
Jianlei Zheng
Qi Xue
Yan Zhao
Publication date
01-11-2019
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 11/2019
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-019-01434-w

Other articles of this Issue 11/2019

Heart and Vessels 11/2019 Go to the issue